Factor Xa Reactive Antibodies In Patients With Systemic LUPUS Erythematosus and Antiphospholipid Syndrome Have Differential Effects Upon Coagulation Assays and Endothelial CELLS

被引：0
|
作者：
Artim-Esen, Bahar [1 ]
Smoktunowicz, Natalia [1 ]
Pericleous, Charis [1 ]
Ripoll, Vera M. [1 ]
Mackie, Ian [1 ]
Chambers, Rachel [1 ]
Isenberg, David A. [1 ]
Rahman, Anisur [1 ]
Ioannou, Yiannis [1 ]
Giles, Ian [1 ]
机构：
[1] UCL, London, England
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
21
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [21] Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
    Navarro, C
    Candia-Zúñiga, L
    Silveira, LH
    Ruiz, V
    Gaxiola, M
    Avila, MC
    Amigo, MC
    LUPUS, 2002, 11 (01) : 21 - 24
  • [22] Effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
    Douketis, J
    Crowther, M
    Julian, J
    Donovan, D
    Stewart, K
    Ginsberg, J
    BLOOD, 1998, 92 (10) : 361A - 361A
  • [23] Prolonged Exposure to Antiphospholipid Antibodies Is Associated with Endothelial Dysfunction in Patients with Systemic Lupus Erythematosus
    Baek, In-Woon
    Park, Yune-Jung
    Kim, Ki-Jo
    Kim, Wan-Uk, Sr.
    Cho, Chul-Soo
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] PROLONGED EXPOSURE TO ANTIPHOSPHOLIPID ANTIBODIES IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Park, Y. -J.
    Baek, I. -W.
    Kim, K. -J.
    Kim, W. -U.
    Cho, C. -S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 890 - 890
  • [25] Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies
    Watanabe, T.
    Oku, K.
    Amengual, O.
    Hisada, R.
    Ohmura, K.
    Nakagawa, I.
    Shida, H.
    Bohgaki, T.
    Horita, T.
    Yasuda, S.
    Atsumi, T.
    LUPUS, 2018, 27 (02) : 225 - 234
  • [26] Antiphospholipid syndrome as a risk factor of cardiovascular complications in systemic lupus erythematosus patients
    Ostanek, L
    Ploñska, E
    Peregud-Pogorzelska, M
    Mokrzycki, K
    Brzosko, M
    Fischer, K
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 252 - 252
  • [27] Von Willebrand factor levels in patients with systemic lupus erythematosus and antiphospholipid syndrome
    Toth, N. K.
    Tarr, T.
    Soltesz, P.
    Sarkady, F.
    Kappelmayer, J.
    Muszbek, L.
    Bagoly, Z.
    CLINICA CHIMICA ACTA, 2022, 530 : S176 - S176
  • [28] Prevalence of Heparin Induced Thrombocytopenia in Hospitalized Patients with Antiphospholipid Syndrome or Systemic Lupus Erythematosus with Antiphospholipid Antibodies
    Tran, Vincent
    Schmitt, Amy
    Kasturi, Shanthini
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1346 - 1347
  • [29] ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE ANALYSIS OF 500 CONSECUTIVE PATIENTS
    ALARCONSEGOVIA, D
    DELEZE, M
    ORIA, CV
    SANCHEZGUERRERO, J
    GOMEZPACHECO, L
    CABIEDES, J
    FERNANDEZ, L
    DELEON, SP
    MEDICINE, 1989, 68 (06) : 353 - 365
  • [30] Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
    Artim-Esen, Bahar
    Smoktunowicz, Natalia
    McDonnell, Thomas
    Ripoll, Vera M.
    Pericleous, Charis
    Mackie, Ian
    Robinson, Eifion
    Isenberg, David
    Rahman, Anisur
    Ioannou, Yiannis
    Chambers, Rachel C.
    Giles, Ian
    SCIENTIFIC REPORTS, 2017, 7
12345